Portfolio Companies News
- 15 December 2011
Zonare Medical Systems Appoints Timothy S. Heher as Vice President of Finance - 13 December 2011
Ambit and Astellas Announce Results From Multiple Quizartinib Presentations At The 53rd Annual Meeting Of The American Hematology Society - 13 December 2011
Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement With Cerner - 6 December 2011
Ulthera Appoints Greg Waller as Chief Financial Officer - 1 December 2011
Astellas and Ambit Announce Data Presentations - 22 November 2011
Radiotherapy for Treatment of Dupuytren's Disease Now Available at Cancer Partners UK Centres - 22 November 2011
Ulthera CEO – Matthew Likens – to Present at Two Upcoming Healthcare Conferences - 21 November 2011
Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944 - 18 November 2011
Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer - 16 November 2011
Frost & Sullivan Honors Zonare For Ultrasound Innovation - 31 October 2011
Wellpartner Signs Agreement with FSAStore.com to Fulfill Prescription Orders - 29 October 2011
Work begins on new image-guided radiotherapy centre in Nottingham - 28 October 2011
Omniguide Appoints Scott Flora as President & CEO - 25 October 2011
South Downs Centre Awarded Macmillan Quality Mark - 22 September 2011
Bristol-Myers Squibb and Ambrx Announce Collaboration for Novel Biologics Programs in Diabetes and Heart Failure - 1 August 2011
By the Bridge Achieves Awards from LILAC - 19 July 2011
Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802 - 18 July 2011
CancerPartnersUK’s CEO Shortlisted for Esteemed Award - 29 June 2011
Zonare Scores in Clinical Applications, Performance and Customer Support & Service in Klas 2011 Ultrasound Report - 20 June 2011
Anaphore Appoints Paul A. Grayson President and CEO - 16 June 2011
Zonare Introduces Vascular Performance and Workflow Enhancements at Vascular Annual Meeting - 13 June 2011
Ambit Announces Interim Data from Phase 2 Trial of AC220 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia - 10 June 2011
Ambit Biosciences Completes $30 Million Series D-2 Financing - 18 May 2011
Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development - 12 April 2011
Convergence Pharmaceuticals Announces Phase I Trial Start of CNV2197944 for Chronic Pain - 31 March 2011
Omniguide - Neurosurgeon Pioneers Use of New Hand-Held Laser to Target Tumors Deep Within The Skull Base - 21 March 2011
Ulthera’s Non-Invasive Skin Tightening Technology Features in Vogue Magazine